,for, Item ID-
  • #1194022
  • AbbVie Inc #00074210001

SKYRIZI® Risankizumab-rzaa 150 mg / mL Injection 1 mL

SKYRIZI, PEN 150MG/ML

AbbVie Inc 00074210001
SKYRIZI® Risankizumab-rzaa 150 mg / mL Injection 1 mL
Compare

Features

  • SKYRIZI® is indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy
  • Single-Dose Pen
  • More …
Container Type
Prefilled Auto-Injector Prefilled Syringe
  Log In to Order
or
 View Alternatives

Product Specifications

Features
  • SKYRIZI® is indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy
  • Single-Dose Pen
More Information

Professionals Also Viewed

    ,for, Item ID-
  • #1242449
  • Novartis #00078116861
COSENTYX® Secukinumab 25 mg / mL Injection 5 mL
  • Carton containing one 125 mg / 5 mL (25 mg / mL) solution in a single- …
    ,for, Item ID-
  • #1194021
  • AbbVie Inc #00074105001
SKYRIZI® Risankizumab-rzaa 150 mg / mL Injection 1 mL
  • SKYRIZI® is indicated for the treatment of moderate-to-severe plaque p …
  • Single-Dose Prefilled Syringe
    ,for, Item ID-
  • #1212567
  • AbbVie US LLC #00074501501
SKYRIZI® Risankizumab-rzaa 60 mg / mL Injection 10 mL
  • SKYRIZI® is indicated for the treatment of moderate-to-severe plaque p …
  • SKYRIZI is indicated for the treatment of active psoriatic arthritis i …
  • SKYRIZI is indicated for the treatment of moderately to severely activ …
    ,for, Item ID-
  • #1212568
  • AbbVie US LLC #00074107001
SKYRIZI® Risankizumab-rzaa 150 mg / mL Injection 2.4 mL
  • SKYRIZI® is indicated for the treatment of moderate-to-severe plaque p …
  • SKYRIZI is indicated for the treatment of active psoriatic arthritis i …
  • SKYRIZI is indicated for the treatment of moderately to severely activ …
Compare Products (0) Clear Compare